>90% of Multiplex Publications with 20+ IHC markers use Imaging Mass Cytometry
The first time I learned this figure I frankly did not believe it (check it out for yourself). I asked, "How could this [...]
Imaging Mass Cytometry Overview Video
Curious to learn more about Visikol's Imaging Mass Cytometry services? Watch the video below for a brief overview! [...]
The Use Case: Brightfield, IF, & IMC
In 2022, Visikol launched a new imaging service in partnership with Standard BioTools Inc, this partnership has allowed us [...]
The Value of Using IMC
Lung cancer has predominated as one of the leading causes of death worldwide, with lung cancer patients facing a [...]
Standard BioTools Announces Collaboration Agreement With Visikol to Offer Multiplex Imaging Mass Cytometry Services
SOUTH SAN FRANCISCO, Calif., October 11, 2022 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose [...]
Download Our New Multiplex Tissue Imaging eBook
Download our Multiplex Tissue Imaging eBook Today! With the recent advances in the field of tumor immunology and cancer immunotherapy, [...]
Visikol uses Multiplex Imaging Tools in Partnership with Hackensack Meridian Health
Tuberculosis (TB) is still one of the top ten leading causes of death globally. Although TB is both preventable [...]
Visikol Launches Multiplex Slide Imaging and Analysis Services
The Visikol research team has developed a novel tissue multiplexing approach which leverages a proprietary antibody [...]
Visikol Partners with Fluidigm to offer its Clients Imaging Mass Cytometry Services
Visikol originally began a little over four years ago focused entirely on providing researchers with reagents to image tissues [...]
Visikol Launches Imaging Mass Cytometry Services
Hampton, NJ --- As a leader in advanced tissue imaging and digital pathology services, Visikol is excited to announce [...]